Portfolio of Bridgewater Associates
Bridgewater Associates was founded by Ray Dalio, who handed over leadership in 2022; the hedge fund follows a macroeconomic approach with a broadly diversified portfolio.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 12, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 18.3B USD
- Positions
- 683
- Share of the ten largest
- 38.4%
The ten largest positions Q3 2021
- Vanguard Intl Equity Index F 6.4%▲ +97.5%
- Ishares TR 5.6%▲ +822.7%
- Ishares Inc 4.7%▲ +224.6%
- SPDR S&P 500 ETF TR 4.6%▼ −0.4%
- Walmart 3.8%▼ −3.8%
- Procter & Gamble 3.6%▼ −1.4%
- Alibaba Group (ADR) 2.7%▲ +131.9%
- Johnson & Johnson 2.4%▼ −2.4%
- Coca-Cola Company (The) 2.4%▲ +1.7%
- PepsiCo 2.2%▲ +0.4%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q3 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| SPDR S&P 500 ETF TR | 4.6% | 1,967,605 | 844.4M USD | −0.4% reduced | Q2 2013 or earlier 34 quarters |
| WMT Walmart | 3.8% | 5,025,736 | 700.5M USD | −3.8% reduced | Q3 2020 5 quarters |
| PG Procter & Gamble | 3.6% | 4,687,538 | 655.3M USD | −1.4% reduced | Q3 2020 5 quarters |
| JNJ Johnson & Johnson | 2.4% | 2,754,036 | 444.8M USD | −2.4% reduced | Q3 2020 5 quarters |
| DHR Danaher Corporation | 1.2% | 703,685 | 214.2M USD | −18.0% reduced | Q3 2020 5 quarters |
| Ishares TR | 0.8% | 1,064,706 | 141.6M USD | −0.9% reduced | Q2 2013 or earlier 34 quarters |
| Ishares Gold TR | 0.7% | 3,805,198 | 127.1M USD | −9.6% reduced | Q2 2021 2 quarters |
| CL Colgate-Palmolive | 0.7% | 1,667,040 | 126.0M USD | −0.4% reduced | Q3 2020 5 quarters |
| ISRG Intuitive Surgical | 0.7% | 124,409 | 123.7M USD | −4.1% reduced | Q3 2020 5 quarters |
| CMG Chipotle Mexican Grill | 0.5% | 54,181 | 98.5M USD | −2.3% reduced | Q3 2020 5 quarters |
| MNST Monster Beverage | 0.5% | 1,019,709 | 90.6M USD | −2.5% reduced | Q3 2020 5 quarters |
| CVS CVS Health | 0.5% | 1,058,275 | 89.8M USD | −11.4% reduced | Q1 2020 7 quarters |
| KMB Kimberly-Clark | 0.5% | 658,452 | 87.2M USD | −1.3% reduced | Q3 2020 5 quarters |
| VEEV Veeva Systems | 0.5% | 296,451 | 85.4M USD | −5.6% reduced | Q3 2020 5 quarters |
| EW Edwards Lifesciences | 0.4% | 689,665 | 78.1M USD | −1.1% reduced | Q3 2020 5 quarters |
| BSX Boston Scientific | 0.4% | 1,539,799 | 66.8M USD | −2.1% reduced | Q3 2020 5 quarters |
| ALGN Align Technology | 0.3% | 80,374 | 53.5M USD | −2.3% reduced | Q3 2020 5 quarters |
| Vanguard Tax-Managed Intl Fd | 0.3% | 1,050,951 | 53.1M USD | −5.7% reduced | Q2 2017 18 quarters |
| Ishares TR | 0.3% | 662,431 | 51.7M USD | −5.7% reduced | Q2 2017 18 quarters |
| DXCM Dexcom | 0.3% | 94,253 | 51.5M USD | −10.6% reduced | Q3 2020 5 quarters |
| BF-B Brown–Forman | 0.3% | 744,996 | 49.9M USD | −3.2% reduced | Q3 2020 5 quarters |
| Ishares TR | 0.3% | 644,560 | 47.9M USD | −5.7% reduced | Q2 2017 18 quarters |
| BAX Baxter International | 0.2% | 566,263 | 45.5M USD | −3.0% reduced | Q3 2020 5 quarters |
| RMD ResMed | 0.2% | 161,349 | 42.5M USD | −2.1% reduced | Q3 2020 5 quarters |
| Kellogg Co | 0.2% | 664,762 | 42.5M USD | −1.0% reduced | Q3 2020 5 quarters |
| DRI Darden Restaurants | 0.2% | 251,360 | 38.1M USD | −0.2% reduced | Q3 2020 5 quarters |
| West Pharmaceutical Svsc Inc | 0.2% | 84,073 | 35.7M USD | −4.0% reduced | Q3 2020 5 quarters |
| Teladoc Health Inc | 0.2% | 270,190 | 34.3M USD | −3.0% reduced | Q4 2020 4 quarters |
| IFF International Flavors & Fragrances | 0.2% | 240,796 | 32.2M USD | −1.4% reduced | Q1 2021 3 quarters |
| Goodrx HLDGS Inc | 0.2% | 690,883 | 28.3M USD | −2.9% reduced | Q2 2021 2 quarters |
| COR Cencora | 0.1% | 213,747 | 25.5M USD | −0.3% reduced | Q3 2020 5 quarters |
| Hologic Inc | 0.1% | 286,082 | 21.1M USD | −7.6% reduced | Q3 2020 5 quarters |
| PODD Insulet Corporation | < 0.1% | 63,417 | 18.0M USD | −3.2% reduced | Q2 2021 2 quarters |
| Bright Horizons Fam Sol In D | < 0.1% | 117,046 | 16.3M USD | −1.7% reduced | Q3 2020 5 quarters |
| Masimo Corp | < 0.1% | 56,753 | 15.4M USD | −10.8% reduced | Q3 2020 5 quarters |
| Abiomed Inc | < 0.1% | 46,547 | 15.2M USD | −4.9% reduced | Q3 2020 5 quarters |
| ECL Ecolab | < 0.1% | 67,976 | 14.2M USD | −46.7% reduced | Q1 2021 3 quarters |
| CASY Casey's | < 0.1% | 71,257 | 13.4M USD | −4.1% reduced | Q3 2020 5 quarters |
| Guardant Health Inc | < 0.1% | 103,958 | 13.0M USD | −4.4% reduced | Q3 2020 5 quarters |
| Texas Roadhouse Inc | < 0.1% | 134,020 | 12.2M USD | −5.2% reduced | Q3 2020 5 quarters |
| Freshpet Inc | < 0.1% | 83,161 | 11.9M USD | −1.0% reduced | Q3 2020 5 quarters |
| Pilgrims Pride Corp | < 0.1% | 399,409 | 11.6M USD | −3.2% reduced | Q3 2020 5 quarters |
| CELH Celsius Holdings | < 0.1% | 128,243 | 11.6M USD | −1.8% reduced | Q1 2021 3 quarters |
| Novocure Ltd | < 0.1% | 96,106 | 11.2M USD | −0.6% reduced | Q2 2021 2 quarters |
| Omnicell Com | < 0.1% | 75,016 | 11.1M USD | −2.5% reduced | Q1 2021 3 quarters |
| Inspire Med Sys Inc | < 0.1% | 47,420 | 11.0M USD | −3.3% reduced | Q1 2021 3 quarters |
| Teleflex Incorporated | < 0.1% | 28,590 | 10.8M USD | −57.8% reduced | Q2 2020 6 quarters |
| Helen Of Troy Ltd | < 0.1% | 46,511 | 10.5M USD | −7.6% reduced | Q3 2020 5 quarters |
| Penumbra Inc | < 0.1% | 36,491 | 9.7M USD | −4.0% reduced | Q3 2020 5 quarters |
| Reynolds Consumer Prods Inc | < 0.1% | 352,824 | 9.6M USD | −1.5% reduced | Q2 2021 2 quarters |
| Oak Str Health Inc | < 0.1% | 224,764 | 9.6M USD | −2.7% reduced | Q2 2021 2 quarters |
| Flowers Foods Inc | < 0.1% | 375,023 | 8.9M USD | −2.9% reduced | Q3 2020 5 quarters |
| Certara Inc | < 0.1% | 265,894 | 8.8M USD | −0.3% reduced | Q2 2021 2 quarters |
| National Beverage Corp | < 0.1% | 165,408 | 8.7M USD | −3.2% reduced | Q4 2020 4 quarters |
| Grand Canyon Ed Inc | < 0.1% | 87,444 | 7.7M USD | −6.9% reduced | Q3 2020 5 quarters |
| Ollies Bargain Outlet HLDGS | < 0.1% | 125,160 | 7.5M USD | −3.8% reduced | Q3 2020 5 quarters |
| Herbalife Nutrition Ltd | < 0.1% | 173,463 | 7.4M USD | −17.0% reduced | Q3 2020 5 quarters |
| Globus Med Inc | < 0.1% | 91,916 | 7.0M USD | −7.5% reduced | Q2 2021 2 quarters |
| Sanderson Farms Inc | < 0.1% | 37,150 | 7.0M USD | −6.4% reduced | Q2 2021 2 quarters |
| Tandem Diabetes Care Inc | < 0.1% | 57,608 | 6.9M USD | −8.0% reduced | Q2 2021 2 quarters |
| Encompass Health Corp | < 0.1% | 89,557 | 6.7M USD | −13.2% reduced | Q1 2021 3 quarters |
| Schrodinger Inc | < 0.1% | 121,982 | 6.7M USD | −2.5% reduced | Q2 2021 2 quarters |
| Shockwave Med Inc | < 0.1% | 32,121 | 6.6M USD | −7.8% reduced | Q2 2021 2 quarters |
| Marketaxess HLDGS Inc | < 0.1% | 15,487 | 6.5M USD | −5.4% reduced | Q4 2020 4 quarters |
| BRO Brown & Brown | < 0.1% | 116,641 | 6.5M USD | −0.1% reduced | Q4 2020 4 quarters |
| Coca Cola Cons Inc | < 0.1% | 15,957 | 6.3M USD | −2.3% reduced | Q2 2021 2 quarters |
| Envista Holdings Corporation | < 0.1% | 147,568 | 6.2M USD | −7.7% reduced | Q2 2021 2 quarters |
| Walgreens Boots Alliance Inc | < 0.1% | 127,909 | 6.0M USD | −20.6% reduced | Q1 2020 7 quarters |
| Quidel Corp | < 0.1% | 42,071 | 5.9M USD | −4.8% reduced | Q3 2020 5 quarters |
| Simply Good Foods Co | < 0.1% | 168,293 | 5.8M USD | −3.0% reduced | Q2 2021 2 quarters |
| ADBE Adobe Inc. | < 0.1% | 9,851 | 5.7M USD | −61.2% reduced | Q2 2021 2 quarters |
| Staar Surgical Co | < 0.1% | 43,329 | 5.6M USD | −7.1% reduced | Q2 2021 2 quarters |
| Wd 40 Co | < 0.1% | 23,735 | 5.5M USD | −3.4% reduced | Q2 2021 2 quarters |
| Phreesia Inc | < 0.1% | 88,036 | 5.4M USD | −3.0% reduced | Q2 2021 2 quarters |
| Shake Shack Inc | < 0.1% | 68,049 | 5.3M USD | −3.3% reduced | Q1 2021 3 quarters |
| Amedisys Inc | < 0.1% | 34,049 | 5.1M USD | −3.5% reduced | Q3 2020 5 quarters |
| J & J Snack Foods Corp | < 0.1% | 32,879 | 5.0M USD | −2.7% reduced | Q2 2021 2 quarters |
| Amn Healthcare Svcs Inc | < 0.1% | 43,599 | 5.0M USD | −8.2% reduced | Q2 2021 2 quarters |
| Evolent Health Inc | < 0.1% | 152,100 | 4.7M USD | −4.0% reduced | Q2 2021 2 quarters |
| Aramark | < 0.1% | 140,643 | 4.6M USD | −43.4% reduced | Q3 2020 5 quarters |
| Lhc Group Inc | < 0.1% | 29,227 | 4.6M USD | −7.3% reduced | Q2 2021 2 quarters |
| Icu Med Inc | < 0.1% | 19,591 | 4.6M USD | −8.1% reduced | Q2 2021 2 quarters |
| REGN Regeneron Pharmaceuticals | < 0.1% | 7,422 | 4.5M USD | −41.5% reduced | Q2 2021 2 quarters |
| Premier Inc | < 0.1% | 113,317 | 4.4M USD | −7.9% reduced | Q2 2021 2 quarters |
| 2U Inc | < 0.1% | 129,554 | 4.3M USD | −3.1% reduced | Q2 2021 2 quarters |
| Neogen Corp | < 0.1% | 99,243 | 4.3M USD | −7.2% reduced | Q2 2021 2 quarters |
| HPQ HP Inc. | < 0.1% | 156,250 | 4.3M USD | −57.1% reduced | Q2 2021 2 quarters |
| Hostess Brands Inc | < 0.1% | 243,103 | 4.2M USD | −4.3% reduced | Q2 2021 2 quarters |
| Central Garden & Pet Co | < 0.1% | 97,703 | 4.2M USD | −2.0% reduced | Q2 2021 2 quarters |
| Pricesmart Inc | < 0.1% | 52,948 | 4.1M USD | −2.4% reduced | Q2 2021 2 quarters |
| Spectrum Brands HLDGS Inc Ne | < 0.1% | 41,233 | 3.9M USD | −4.7% reduced | Q2 2021 2 quarters |
| Medifast Inc | < 0.1% | 20,376 | 3.9M USD | −2.8% reduced | Q2 2021 2 quarters |
| American Well Corp | < 0.1% | 422,389 | 3.8M USD | −2.4% reduced | Q2 2021 2 quarters |
| Irobot Corp | < 0.1% | 48,808 | 3.8M USD | −3.2% reduced | Q2 2021 2 quarters |
| Nevro Corp | < 0.1% | 32,334 | 3.8M USD | −7.0% reduced | Q2 2021 2 quarters |
| Inari Med Inc | < 0.1% | 46,261 | 3.8M USD | −7.4% reduced | Q2 2021 2 quarters |
| Merit Med Sys Inc | < 0.1% | 52,222 | 3.8M USD | −7.9% reduced | Q2 2021 2 quarters |
| Barrick Gold Corp | < 0.1% | 204,008 | 3.7M USD | −3.5% reduced | Q4 2020 4 quarters |
| Beyond Meat Inc | < 0.1% | 34,269 | 3.6M USD | −3.7% reduced | Q3 2020 5 quarters |
| BIIB Biogen | < 0.1% | 12,622 | 3.6M USD | −29.3% reduced | Q1 2021 3 quarters |
| Sei Invts Co | < 0.1% | 58,382 | 3.5M USD | −2.3% reduced | Q4 2020 4 quarters |
| Haemonetics Corp Mass | < 0.1% | 47,669 | 3.4M USD | −8.2% reduced | Q2 2021 2 quarters |
| VTRS Viatris | < 0.1% | 246,912 | 3.3M USD | −16.8% reduced | Q1 2021 3 quarters |
| Usana Health Sciences Inc | < 0.1% | 35,035 | 3.2M USD | −4.1% reduced | Q2 2021 2 quarters |
| Adtalem Global Ed Inc | < 0.1% | 85,323 | 3.2M USD | −3.3% reduced | Q2 2021 2 quarters |
| Corvel Corp | < 0.1% | 16,755 | 3.1M USD | −8.4% reduced | Q2 2021 2 quarters |
| GILD Gilead Sciences | < 0.1% | 44,619 | 3.1M USD | −64.8% reduced | Q4 2020 4 quarters |
| Cal Maine Foods Inc | < 0.1% | 85,569 | 3.1M USD | −3.7% reduced | Q2 2021 2 quarters |
| Strategic Ed Inc | < 0.1% | 43,115 | 3.0M USD | −3.9% reduced | Q2 2021 2 quarters |
| BXP BXP, Inc. | < 0.1% | 27,829 | 3.0M USD | −15.1% reduced | Q1 2021 3 quarters |
| Atricure Inc | < 0.1% | 41,930 | 2.9M USD | −3.4% reduced | Q2 2021 2 quarters |
| Nuvasive Inc | < 0.1% | 48,430 | 2.9M USD | −7.4% reduced | Q2 2021 2 quarters |
| Cryoport Inc | < 0.1% | 43,115 | 2.9M USD | −7.8% reduced | Q2 2021 2 quarters |
| Adapthealth Corp | < 0.1% | 122,293 | 2.8M USD | −6.6% reduced | Q2 2021 2 quarters |
| Axonics Inc | < 0.1% | 43,104 | 2.8M USD | −7.3% reduced | Q2 2021 2 quarters |
| Vocera Communications Inc | < 0.1% | 61,081 | 2.8M USD | −3.5% reduced | Q2 2021 2 quarters |
| WY Weyerhaeuser | < 0.1% | 78,435 | 2.8M USD | −1.1% reduced | Q4 2019 8 quarters |
| Integer HLDGS Corp | < 0.1% | 31,049 | 2.8M USD | −7.5% reduced | Q2 2021 2 quarters |
| VRTX Vertex Pharmaceuticals | < 0.1% | 15,117 | 2.7M USD | −35.0% reduced | Q4 2020 4 quarters |
| E L F Beauty Inc | < 0.1% | 91,097 | 2.6M USD | −3.7% reduced | Q2 2021 2 quarters |
| Stride Inc | < 0.1% | 73,386 | 2.6M USD | −4.2% reduced | Q2 2021 2 quarters |
| Heska Corp | < 0.1% | 9,994 | 2.6M USD | −6.9% reduced | Q2 2021 2 quarters |
| Big Lots Inc | < 0.1% | 59,081 | 2.6M USD | −2.6% reduced | Q2 2021 2 quarters |
| Mgp Ingredients Inc New | < 0.1% | 38,631 | 2.5M USD | −3.6% reduced | Q2 2021 2 quarters |
| Fulgent Genetics Inc | < 0.1% | 27,770 | 2.5M USD | −7.0% reduced | Q2 2021 2 quarters |
| Modivcare Inc | < 0.1% | 13,307 | 2.4M USD | −7.9% reduced | Q2 2021 2 quarters |
| Bausch Health Cos Inc | < 0.1% | 85,767 | 2.4M USD | −25.6% reduced | Q4 2020 4 quarters |
| Kilroy Rlty Corp | < 0.1% | 36,011 | 2.4M USD | −8.1% reduced | Q1 2021 3 quarters |
| ILMN Illumina, Inc. | < 0.1% | 5,705 | 2.3M USD | −48.0% reduced | Q2 2021 2 quarters |
| Mednax Inc | < 0.1% | 79,110 | 2.2M USD | −4.2% reduced | Q2 2021 2 quarters |
| Ingles Mkts Inc | < 0.1% | 33,640 | 2.2M USD | −3.7% reduced | Q2 2021 2 quarters |
| Outset Med Inc | < 0.1% | 44,034 | 2.2M USD | −7.0% reduced | Q2 2021 2 quarters |
| Vmware Inc | < 0.1% | 14,305 | 2.1M USD | −92.3% reduced | Q2 2021 2 quarters |
| Glaukos Corp | < 0.1% | 44,124 | 2.1M USD | −5.8% reduced | Q2 2021 2 quarters |
| Silk Rd Med Inc | < 0.1% | 33,454 | 1.8M USD | −6.4% reduced | Q2 2021 2 quarters |
| ZTS Zoetis | < 0.1% | 9,058 | 1.8M USD | −58.7% reduced | Q2 2021 2 quarters |
| Lantheus HLDGS Inc | < 0.1% | 65,646 | 1.7M USD | −6.2% reduced | Q2 2021 2 quarters |
| Nextgen Healthcare Inc | < 0.1% | 119,058 | 1.7M USD | −1.0% reduced | Q2 2021 2 quarters |
| Biolife Solutions Inc | < 0.1% | 39,524 | 1.7M USD | −5.9% reduced | Q2 2021 2 quarters |
| Irhythm Technologies Inc | < 0.1% | 28,560 | 1.7M USD | −5.5% reduced | Q2 2021 2 quarters |
| Castle Biosciences Inc | < 0.1% | 24,470 | 1.6M USD | −5.8% reduced | Q2 2021 2 quarters |
| Cgi Inc | < 0.1% | 18,951 | 1.6M USD | −42.6% reduced | Q4 2020 4 quarters |
| Mesa Labs Inc | < 0.1% | 5,087 | 1.5M USD | −4.6% reduced | Q2 2021 2 quarters |
| MSFT Microsoft | < 0.1% | 5,364 | 1.5M USD | −94.8% reduced | Q4 2020 4 quarters |
| Avanos Med Inc | < 0.1% | 47,216 | 1.5M USD | −4.9% reduced | Q2 2021 2 quarters |
| Simulations Plus Inc | < 0.1% | 36,751 | 1.5M USD | −1.0% reduced | Q2 2021 2 quarters |
| U S Physical Therapy | < 0.1% | 12,691 | 1.4M USD | −5.0% reduced | Q2 2021 2 quarters |
| Perdoceo Ed Corp | < 0.1% | 129,043 | 1.4M USD | −1.2% reduced | Q2 2021 2 quarters |
| Ruths Hospitality Group Inc | < 0.1% | 64,164 | 1.3M USD | −1.2% reduced | Q2 2021 2 quarters |
| Cardiovascular Sys Inc Del | < 0.1% | 39,920 | 1.3M USD | −4.2% reduced | Q2 2021 2 quarters |
| Orthopediatrics Corp | < 0.1% | 19,696 | 1.3M USD | −4.2% reduced | Q2 2021 2 quarters |
| Atrion Corp | < 0.1% | 1,825 | 1.3M USD | −4.0% reduced | Q2 2021 2 quarters |
| Addus Homecare Corp | < 0.1% | 15,822 | 1.3M USD | −4.1% reduced | Q2 2021 2 quarters |
| NTAP NetApp | < 0.1% | 13,972 | 1.3M USD | −84.2% reduced | Q2 2021 2 quarters |
| Kinross Gold Corp | < 0.1% | 226,513 | 1.2M USD | −27.2% reduced | Q4 2020 4 quarters |
| Blackberry Ltd | < 0.1% | 121,732 | 1.2M USD | −18.3% reduced | Q4 2020 4 quarters |
| AKAM Akamai Technologies | < 0.1% | 10,413 | 1.1M USD | −30.8% reduced | Q2 2021 2 quarters |
| Biomarin Pharmaceutical Inc | < 0.1% | 14,010 | 1.1M USD | −39.6% reduced | Q1 2021 3 quarters |
| National Healthcare Corp | < 0.1% | 15,469 | 1.1M USD | −2.4% reduced | Q2 2021 2 quarters |
| Crescent Pt Energy Corp | < 0.1% | 232,668 | 1.1M USD | −1.2% reduced | Q1 2014 31 quarters |
| Cerus Corp | < 0.1% | 175,280 | 1.1M USD | −2.5% reduced | Q2 2021 2 quarters |
| Angiodynamics Inc | < 0.1% | 39,956 | 1.0M USD | −0.4% reduced | Q2 2021 2 quarters |
| National Resh Corp | < 0.1% | 22,275 | 939.0K USD | −3.7% reduced | Q2 2021 2 quarters |
| Washington Fed Inc | < 0.1% | 27,259 | 935.0K USD | −10.0% reduced | Q4 2020 4 quarters |
| PLD Prologis | < 0.1% | 7,222 | 906.0K USD | −36.4% reduced | Q2 2021 2 quarters |
| Wheaton Precious Metals Corp | < 0.1% | 23,665 | 891.0K USD | −14.2% reduced | Q4 2020 4 quarters |
| SLB Schlumberger | < 0.1% | 29,584 | 877.0K USD | −4.2% reduced | Q4 2020 4 quarters |
| Canopy Growth Corp | < 0.1% | 62,733 | 869.0K USD | −13.5% reduced | Q4 2020 4 quarters |
| Agnico Eagle Mines Ltd | < 0.1% | 16,732 | 868.0K USD | −3.5% reduced | Q4 2020 4 quarters |
| A Agilent Technologies | < 0.1% | 5,453 | 859.0K USD | −94.9% reduced | Q2 2021 2 quarters |
| Yamana Gold Inc | < 0.1% | 207,391 | 819.0K USD | −7.8% reduced | Q2 2013 or earlier 34 quarters |
| Cameco Corp | < 0.1% | 36,116 | 785.0K USD | −3.5% reduced | Q4 2020 4 quarters |
| FLEX Flex Ltd. | < 0.1% | 39,254 | 694.0K USD | −79.6% reduced | Q2 2021 2 quarters |
| Seagen Inc | < 0.1% | 4,006 | 680.0K USD | −60.4% reduced | Q2 2021 2 quarters |
| B2GOLD Corp | < 0.1% | 198,327 | 678.0K USD | −13.6% reduced | Q4 2020 4 quarters |
| Franco Nev Corp | < 0.1% | 5,115 | 664.0K USD | −3.4% reduced | Q4 2020 4 quarters |
| Okta Inc | < 0.1% | 2,751 | 653.0K USD | −62.1% reduced | Q2 2021 2 quarters |
| Capitol Fed Finl Inc | < 0.1% | 53,108 | 610.0K USD | −6.3% reduced | Q4 2020 4 quarters |
| Ssr Mng Inc | < 0.1% | 41,771 | 607.0K USD | −45.5% reduced | Q4 2020 4 quarters |
| Stantec Inc | < 0.1% | 11,918 | 560.0K USD | −53.9% reduced | Q4 2020 4 quarters |
| Discovery Inc | < 0.1% | 21,957 | 557.0K USD | −1.6% reduced | Q4 2020 4 quarters |
| CSCO Cisco | < 0.1% | 9,866 | 537.0K USD | −94.1% reduced | Q4 2020 4 quarters |
| WM Waste Management | < 0.1% | 3,544 | 529.0K USD | −3.6% reduced | Q2 2021 2 quarters |
| VRSN Verisign | < 0.1% | 2,549 | 523.0K USD | −57.5% reduced | Q1 2021 3 quarters |
| Fleetcor Technologies Inc | < 0.1% | 1,927 | 503.0K USD | −56.2% reduced | Q2 2021 2 quarters |
| Alnylam Pharmaceuticals Inc | < 0.1% | 2,234 | 422.0K USD | −63.4% reduced | Q2 2021 2 quarters |
| INCY Incyte | < 0.1% | 6,047 | 416.0K USD | −78.6% reduced | Q2 2021 2 quarters |
| Colliers Intl Group Inc | < 0.1% | 3,023 | 387.0K USD | −3.3% reduced | Q1 2021 3 quarters |
| BKR Baker Hughes | < 0.1% | 15,605 | 386.0K USD | −41.0% reduced | Q4 2020 4 quarters |
| Transunion | < 0.1% | 3,364 | 378.0K USD | −67.4% reduced | Q2 2021 2 quarters |
| Cae Inc | < 0.1% | 12,523 | 374.0K USD | −30.2% reduced | Q4 2020 4 quarters |
| SIRI Sirius XM | < 0.1% | 58,993 | 360.0K USD | −67.4% reduced | Q1 2021 3 quarters |
| Ritchie Bros Auctioneers | < 0.1% | 5,758 | 355.0K USD | −18.2% reduced | Q4 2020 4 quarters |
| Pretium Res Inc | < 0.1% | 36,643 | 354.0K USD | −15.3% reduced | Q4 2020 4 quarters |
| Cronos Group Inc | < 0.1% | 61,927 | 350.0K USD | −50.5% reduced | Q4 2020 4 quarters |
| Dennys Corp | < 0.1% | 21,250 | 347.0K USD | −32.1% reduced | Q2 2021 2 quarters |
| Pan Amern Silver Corp | < 0.1% | 14,710 | 342.0K USD | −3.5% reduced | Q4 2020 4 quarters |
| Brp Inc | < 0.1% | 3,627 | 336.0K USD | −3.5% reduced | Q4 2020 4 quarters |
| TYL Tyler Technologies | < 0.1% | 726 | 333.0K USD | −66.3% reduced | Q2 2021 2 quarters |
| Equinox Gold Corp | < 0.1% | 50,329 | 332.0K USD | −9.8% reduced | Q4 2020 4 quarters |
| Neurocrine Biosciences Inc | < 0.1% | 3,197 | 307.0K USD | −46.1% reduced | Q2 2021 2 quarters |
| Eldorado Gold Corp New | < 0.1% | 39,186 | 303.0K USD | −44.0% reduced | Q4 2020 4 quarters |
| Centerra Gold Inc | < 0.1% | 41,479 | 283.0K USD | −42.7% reduced | Q2 2021 2 quarters |
| T AT&T | < 0.1% | 10,447 | 282.0K USD | −6.6% reduced | Q2 2021 2 quarters |
| CNC Centene Corporation | < 0.1% | 4,465 | 278.0K USD | −83.6% reduced | Q2 2021 2 quarters |
| JKHY Jack Henry & Associates | < 0.1% | 1,670 | 274.0K USD | −56.8% reduced | Q2 2021 2 quarters |
| NWSA News Corp (Class A) | < 0.1% | 11,222 | 264.0K USD | −94.4% reduced | Q2 2021 2 quarters |
| GDDY GoDaddy | < 0.1% | 3,740 | 261.0K USD | −58.0% reduced | Q2 2021 2 quarters |
| Cable One Inc | < 0.1% | 134 | 243.0K USD | −59.3% reduced | Q2 2021 2 quarters |
| Booz Allen Hamilton Hldg Cor | < 0.1% | 3,000 | 238.0K USD | −58.8% reduced | Q2 2021 2 quarters |
| Zoominfo Technologies Inc | < 0.1% | 3,661 | 224.0K USD | −62.4% reduced | Q2 2021 2 quarters |
| MSI Motorola Solutions | < 0.1% | 937 | 218.0K USD | −98.3% reduced | Q2 2021 2 quarters |
| DASH DoorDash | < 0.1% | 1,045 | 215.0K USD | −92.8% reduced | Q2 2021 2 quarters |
| Iamgold Corp | < 0.1% | 91,833 | 208.0K USD | −45.1% reduced | Q4 2020 4 quarters |
| New Gold Inc Cda | < 0.1% | 110,566 | 117.0K USD | −54.0% reduced | Q4 2020 4 quarters |
| Eargo Inc | < 0.1% | 12,765 | 86.0K USD | −68.3% reduced | Q2 2021 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Consumer Staples 22.3%
- Health Care 11.8%
- Consumer Discretionary 6.2%
- Financials 4.8%
- Industrials 2.2%
- Materials 1.0%
- Technology 0.3%
- Communication Services 0.2%
- Real Estate 0.1%
- Utilities < 0.1%
- Energy < 0.1%
- not in our coverage 51.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors